PhaseBio Pharmaceuticals, Inc. (PHAS)

Cash Conversion Ratio

382.20×

TTM · Retrieved:

PHAS logo

PHAS Cash Conversion Ratio

Current (TTM)382.20×
PHAS Cash Conversion Ratio (0.72× → 382.20×)
High-resolution chart · PNG

PHAS cash conversion ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Cash Conversion Ratio — Annual fiscal periods
Period endingCash Conversion Ratio
382.1974×
0.6226×
1.0333×
0.7201×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.